These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 50644)
41. A new specificity, SH7 (Bw75), defined by antisera produced by planned immunization. Zhao TM; Lee TD; Davey RJ; Simonis T; Lee G; Miller WV Tissue Antigens; 1988 Aug; 32(2):93-9. PubMed ID: 2461603 [TBL] [Abstract][Full Text] [Related]
42. Antisera against HLA-C-series antigens in a test system for antibody-dependent lymphocyte-mediated cyotoxicity (LALI). Dickmeiss E; Nielsen LS Tissue Antigens; 1976 Apr; 7(4):247-9. PubMed ID: 941130 [No Abstract] [Full Text] [Related]
43. [Cross reactions and inclusions in the HL-A system]. Seignalet J Rev Eur Etud Clin Biol; 1972 Mar; 17(3):273-86. PubMed ID: 4115431 [No Abstract] [Full Text] [Related]
46. Interaction of Fc and C3 receptors of lymphoid cells with antibodies against products of the major histocompatibility complex: association of MHC products with complement receptors. Schirrmacher V; Festenstein H Transplant Rev; 1976; 30():140-73. PubMed ID: 59971 [No Abstract] [Full Text] [Related]
47. Streptococcal M protein vaccines, rheumatic fever and human histocompatibility antigens. Fox EN; Peterson RD J Immunol; 1970 Oct; 105(4):1031-2. PubMed ID: 4097139 [No Abstract] [Full Text] [Related]
48. The lymphocyte membrane. Schlesinger M Ser Haematol; 1974; 7(4):427-45. PubMed ID: 4141795 [No Abstract] [Full Text] [Related]
49. Classification of inbred rat strains for Ag-B histocompatibility antigens. Palm J Transplant Proc; 1971 Mar; 3(1):169-71. PubMed ID: 4106302 [No Abstract] [Full Text] [Related]
50. Population data on two new HLA-D determinants, EI and RE. Grosse-Wilde H; Hauptmann G; Johannsen R; Netzel B; Rittner C; Ruppelt W Scand J Immunol; 1977; 6(5):515-21. PubMed ID: 70072 [TBL] [Abstract][Full Text] [Related]
51. HLA serum screening based on an heuristic solution of the set cover problem. Woodbury MA; Ciftan EA; Amos DB Comput Programs Biomed; 1979 May; 9(3):263-73. PubMed ID: 86406 [TBL] [Abstract][Full Text] [Related]
52. Preparation of monospecific HLA antibodies from cross-reactive multispecific antisera. Cross DE; Whittier FC; Greiner RF; Foxworth J; Weaver P; Ross JA Tissue Antigens; 1976 Aug; 8(2):101-8. PubMed ID: 968895 [No Abstract] [Full Text] [Related]
53. Effect of pregnancy on the reactions of lymphocytes with cytotoxic antisera. Taylor PA; Rachkewich RA; Gare DJ; Falk JA; Shumak KH; Crookston MC Transplantation; 1974 Jan; 17(1):142-6. PubMed ID: 4855590 [No Abstract] [Full Text] [Related]
54. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation. Lesley J; Hyman R; Dennert G J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238 [No Abstract] [Full Text] [Related]
55. Cross-reactivity of anti-DRw sera evaluated by serologic studies on established B-lymphoid cell lines. Antonelli P; Kamoun M; Hansen JA; Dupont B Transplant Proc; 1978 Dec; 10(4):849-51. PubMed ID: 83719 [No Abstract] [Full Text] [Related]
56. Identification of an HLA-DR-associated system of B-cell alloantigens. Duquesnoy RJ; Marrari M; Annen K Transplant Proc; 1979 Dec; 11(4):1757-60. PubMed ID: 93800 [No Abstract] [Full Text] [Related]
57. The HLA linkage group. van Rood JJ; van Leeuwen A; Termijtelen A; Keuning JJ Exp Hematol; 1976 Jul; 4(4):237-42. PubMed ID: 60249 [No Abstract] [Full Text] [Related]